Physician profile
Prabhat Soni
NPI 1154376499
$1,856.17
in general payments reported to CMS, 2019-2025
7 companies · $24.09 in 2025
The $24.09 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,388 · 2020: $20.34 · 2021: $62.11 · 2022: $87.80 · 2023: $164 · 2024: $109 · 2025: $24.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,255.11 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $316.40 | 2019-2024 | Fasenra |
| Sumitomo Pharma America, INC. | $84.96 | 2023 | Gemtesa |
| Philips North America LLC | $80.45 | 2019-2021 | |
| Novo Nordisk INC | $59.00 | 2023-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $42.68 | 2022 | |
| Phadia US INC. | $17.57 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabhat Soni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.